Cuestas R A
Pediatr Res. 1980 Aug;14(8):935-8. doi: 10.1203/00006450-198008000-00008.
Serial measurements of serum creatine kinase isoenzymes were done from birth to 15 days of age in healthy premature infants, infants with perinatal or neonatal asphyxia and infants without asphyxia but with miscellaneous problems. Serum brain-specific fraction of creatine kinase (CK-BB) activity was higher in cord than in maternal serum (P < 0.01). In healthy infants, the serum activity of heart- and muscle-specific fractions of creatine kinase increased after birth, reached a plateau between 12 and 48 hr, and then declined, whereas the serum CK-BB decreased rapidly after birth and remained stable between 6 hr and 15 days. Compared to controls, infants with severe asphyxia and neurologic damage had a significant rise in serum CK-BB (P < 0.001). When the peak CK-BB level exceeded 35 IU/liter the mortality was high (83%). The increase in CK-BB was not observed in infants who received pentobarbital shortly after the episode of asphyxia. Diseases of the lung, kidneys, gastrointestinal tract, and abruptio placentae were not associated with increases of serum creatine kinase isoenzymes.
对健康早产儿、有围产期或新生儿窒息的婴儿以及无窒息但有其他问题的婴儿,从出生至15日龄进行了血清肌酸激酶同工酶的系列测定。血清脑特异性肌酸激酶(CK-BB)活性在脐带血中高于母血(P < 0.01)。在健康婴儿中,肌酸激酶的心脏和肌肉特异性组分的血清活性在出生后升高,在12至48小时之间达到平台期,然后下降,而血清CK-BB在出生后迅速下降,并在6小时至15天之间保持稳定。与对照组相比,患有严重窒息和神经损伤的婴儿血清CK-BB显著升高(P < 0.001)。当CK-BB峰值水平超过35 IU/升时,死亡率很高(83%)。在窒息发作后不久接受戊巴比妥治疗的婴儿中未观察到CK-BB升高。肺部、肾脏、胃肠道疾病以及胎盘早剥与血清肌酸激酶同工酶升高无关。